Yttrium-90 microsphere radioembolization for treatment of lung cancer hepatic metastases

Case Reports in Oncology

Volumn 5, Issue 2, 2012, Pages 479-486

  Gaba, Ron C ^a   Lakhoo, Janesh ^a  

^a UNIVERSITY OF ILLINOIS HOSPITAL AND HEALTH SCIENCES SYSTEM   (United States)

Author keywords

Liver metastases; Lung cancer; Yttrium 90 radioembolization

Indexed keywords

CARBOPLATIN; CETUXIMAB; CISPLATIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; MACROSALB TC 99M; MICROSPHERE Y 90; PACLITAXEL; RADIOACTIVE MICROSPHERE; THERASPHERE; UNCLASSIFIED DRUG; YTTRIUM 90;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; BRONCHOSCOPY; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURGERY; CASE REPORT; CHEMORADIOTHERAPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DYSPNEA; FEMALE; FEMORAL ARTERY; FOLLOW UP; HEMOSTASIS; HEPATIC ARTERY; HUMAN; INTERVENTIONAL RADIOLOGY; LIVER ARTERIOGRAPHY; LIVER FUNCTION; LIVER INJURY; LIVER METASTASIS; LIVER NECROSIS; LOBECTOMY; LUNG CANCER; LUNG LAVAGE; LUNG LOBE; LUNG SQUAMOUS CELL CARCINOMA; MOUTH SQUAMOUS CELL CARCINOMA; MULTIPLE CYCLE TREATMENT; NECK DISSECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL SURGERY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PULMONARY SHUNT; RADIATION DOSE; SMOKING; THORAX RADIOGRAPHY; TONGUE; TRANSBRONCHIAL ASPIRATION; TRANSTHORACIC BIOPSY; TREATMENT RESPONSE; TUMOR DIFFERENTIATION; TUMOR VASCULARIZATION; TUMOR VOLUME; ULTRASOUND; VASCULAR ACCESS; WHOLE BODY PET;

EID: 84866871276     PISSN: None     EISSN: 16626575     Source Type: Journal    
DOI: 10.1159/000342706     Document Type: Article

References (22)

1. Memon K, Lewandowski RJ, Kulik L, Riaz A, Mulcahy MF, Salem R: Radioembolization for primary and metastatic liver cancer. Semin Radiat Oncol 2011;21:294-302.
2. Salem R, Thurston KG: Radioembolization with 90Yttrium microspheres: A state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations. J Vasc Interv Radiol 2006;17:1251-1278.
3. Breedis C, Young G: The blood supply of neoplasms in the liver. Am J Pathol 1954;30:969-977.
4. Kennedy AS, Nutting C, Coldwell D, Gaiser J, Drachenberg C: Pathologic response and microdosimetry of (90)Y microspheres in man: Review of four explanted whole livers. Int J Radiat Oncol Biol Phys 2004;60:1552-1563.
5. Salem R, Thurston KG: Radioembolization with yttrium-90 microspheres: A state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: Part 3: Comprehensive literature review and future direction. J Vasc Interv Radiol 2006;17:1571-1593.
6. Mulcahy MF, Lewandowski RJ, Ibrahim SM, et al: Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres. Cancer 2009;115:1849-1858.
7. Kennedy AS, Dezarn WA, McNeillie P, et al: Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: Early results in 148 patients. Am J Clin Oncol 2008;31:271-279.
8. Jakobs TF, Hoffmann RT, Fischer T, et al: Radioembolization in patients with hepatic metastases from breast cancer. J Vasc Interv Radiol 2008;19:683-690.
9. Murthy R, Mutha P, Lee JH, Oh Y: Yttrium-90-labeled microsphere radioembolotherapy of liver-dominant metastases from thoracic malignancies. J Vasc Interv Radiol 2008;19:299-300.
10. Ahmadzadehfar H, Biersack HJ, Ezziddin S: Radioembolization of liver tumors with yttrium-90 microspheres. Semin Nucl Med 2010;40:105-121.
11. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
12. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
13. Kagohashi K, Satoh H, Ishikawa H, Ohtsuka M, Sekizawa K: Liver metastasis at the time of initial diagnosis of lung cancer. Med Oncol 2003;20:25-28.
14. Disibio G, French SW: Metastatic patterns of cancers: Results from a large autopsy study. Arch Pathol Lab Med 2008;132:931-939.
15. Goldstraw P, Crowley J, Chansky K, et al: The IASLC Lung Cancer Staging Project: Proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007;2:706-714.
16. Fouad H, Metzger T, Tatum C, Robbins K, Martin RC: Hepatic arterial therapy with drug-eluting beads in the management of metastatic bronchogenic carcinoma to the liver: A multi-institutional registry. J Oncol 2012;2012:292131.
17. Salem R, Thurston KG: Radioembolization with 90yttrium microspheres: A state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: Special topics. J Vasc Interv Radiol 2006;17:1425-1439.
18. SIRflox: Http://www.sirflox.com/home (accessed July 19, 2012).
19. Salem R, Lewandowski RJ, Sato KT, et al: Technical aspects of radioembolization with 90Y microspheres. Tech Vasc Interv Radiol 2007;10:12-29.
20. Leung TW, Lau WY, Ho SK, et al: Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors. Int J Radiat Oncol Biol Phys 1995;33:919-924.
21. Salem R, Parikh P, Atassi B, et al: Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution. Am J Clin Oncol 2008;31:431-438.
22. Tsujino K, Hirota S, Endo M, et al: Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 2003;55:110-115.